INTRODUCTION
There has been considerable recent interest in serum total sialic acid (TSA). Serum TSA has been shown to be a cardiovascular risk factor, with elevated concentrations Key words : blood pressure, cardiovascular risk factor, hyperinsulinaemia, insulin resistance, lipids, serum sialic acid.
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Correspondence : Dr M. A. Crook. associated with increased cardiovascular mortality [1] and also cerebrovascular disease [2] . Furthermore, serum TSA is elevated in patients with myocardial infarction [3, 4] and in subjects with certain hyperlipidaemias [5, 6] .
It has been shown previously [7] that serum TSA is elevated in patients with Type II (non-insulin-dependent) diabetes mellitus and also in Type I (insulin-dependent) diabetes patients with complications [8] . It has also been reported that serum TSA was higher in Type I diabetes patients with microalbuminuria and macroalbuminuria as compared with normoalbuminuria [9] . Other studies have found a strong univariate correlation between elevated serum TSA and coronary artery disease in male subjects with Type II diabetes [10] . The reason why serum TSA is a reputed cardiovascular risk factor is not clear although its relationship with serum lipids, Type II diabetes and cardiovascular disease raises the possibility that it could be associated with insulin resistance or hyperinsulinaemia. Indeed, Flynn et al. [11] have proposed that insulin resistance results in an elevation of serum TSA. However, it has also been suggested that serum TSA is a marker of atheroma, being increased as a result of inflammatory responses due to atherosclerosis [1] . Surprisingly, it is still unclear whether there is a relationship between serum TSA and other reputed cardiovascular risk factors such as fasting plasma insulin and fasting glucose, and also the insulin resistance index (IRI), which would be pertinent to the aforementioned studies. The aim of this study was to examine this relationship, and also to test the hypothesis that serum TSA may be related to the more traditional risk factors for cardiovascular disease, namely cholesterol, triacylglycerol and high-density lipoprotein (HDL)-cholesterol along with blood pressure, waist\hip ratio and body mass index. We chose to do this in young healthy individuals in whom the likelihood of significant atherosclerosis was small so that our findings would be less likely to be confounded by atheroma resulting in an elevation of serum TSA as discussed above [1] .
METHODS Subjects
One-hundred healthy young subjects (54 females and 46 males) were recruited after obtaining informed consent and the approval of Guy's Hospital Ethical Committee. Subjects were mainly university or graduate students. Their age was 20.7p0.89 years. None had known malignant disease, inflammatory disease, diabetes mellitus or cardiovascular disease or had undergone recent operation at the time of study. In addition, none was on diabetic, anti-hypertensive or lipid-lowering medication at the time of the study. Subjects had been fasting for at least 12 h overnight before venepuncture. About 20 ml of blood was taken and samples were immediately separated from erythrocytes and frozen at k70 mC before analysis. A serum sample was taken for cholesterol, triacylglycerol and HDL-cholesterol assay, and a plasma sample was collected for glucose and insulin concentrations. After a 5-min rest, supine arterial systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured to the nearest 2 mmHg using a standard mercury sphygmomanometer. The systolic first phase and the diastolic fifth phase were used on each occasion. Subject weight and height were recorded in indoor clothing but without shoes and body mass index was calculated using the formula kg\m#. Hip and waist girth were measured, using a tape measure by the same observer, at the maximum circumference at the level of the greater trochanter and half the distance between the lower rib margin and the level of the anterior iliac spine respectively.
Assays
Total serum sialic acid was assayed using an enzymic method supplied by Boehringer Mannheim (Lewes, Sussex, U.K.) and adapted for use on a Roche Cobas Bio or Fara analyser (Roche, Welwyn, Herts, U.K.). The between-batch coefficient of variation of this assay was 3.8 %. This assay has been well characterized and previously published [3] . Serum cholesterol and triacylglycerol were assayed by conventional enzymic colorimetric methods on a Cobas Fara analyser with reagents supplied by Boehringer Mannheim. Serum HDL-cholesterol was similarly measured in the supernatant after precipitation of other lipoproteins with dextran\ magnesium chloride reagent. Plasma glucose was assayed by the glucose oxidase method on a Cobas Fara analyser with reagents from Boehringer Mannheim. Plasma insulin was assayed by an in-house radioimmunoassay and had a minimal detection limit of 1 m-unit\l and an analytical range as determined by precision profiles of 2-200 m-units\l. The intra-assay coefficient of variation was less than 7 % for all these assays.
Calculations/statistics
Correlation between variables was determined using the Spearman rank test. Differences between non-parametric data were calculated using the Mann-Whitney test. Statistical significance was taken as P 0.05. Results are shown as the meanpS.D. or ranges in parentheses if not normally distributed. The IRI was calculated from the following equation: fasting plasma insulin concentration\ 22.5ekln fasting plasma glucose concentration [12] .
RESULTS
The clinical characteristics of the subjects, including serum TSA, cholesterol, triacylglycerol and HDL-cholesterol, are shown in Table 1 . Spearman correlation coefficients (ρ) for TSA and these variables are shown in Serum sialic acid and other cardiovascular risk factors Table 2 . There were significant correlations between serum TSA and serum cholesterol (ρ l 0.38, P 0.01), serum triacylglycerol (ρ l 0.25, P 0.05), plasma fasting glucose (ρ l 0.31, P 0.01), plasma fasting insulin (ρ l 0.33, P 0.01) and IRI (ρ l 0.38, P 0.01) in the group as a whole. There was a significant univariate positive correlation of serum TSA with weight, body mass index, hip circumference, SBP, serum fasting cholesterol and triacylglycerol, plasma fasting insulin, plasma fasting glucose and IRI in the female subjects. There was a significant negative correlation between serum TSA and waist\hip ratio and positive correlations between serum TSA and serum fasting cholesterol and triacylglycerol and also fasting plasma glucose and IRI in the male subjects. Stepwise multiple regression coefficients are shown in Table 3 for serum TSA and the other variables for all the subjects. In this model, plasma fasting insulin, serum cholesterol and plasma fasting glucose were significantly correlated with serum TSA as the dependent variable. Table 4 shows the stepwise multiple regression data for serum TSA and other variables in females and males separately. In the females, when serum TSA was put into a model as the dependent variable, DBP, SBP, serum cholesterol and fasting plasma glucose were significantly positively correlated. Conversely, in the males with serum TSA as the dependent variable, none of the other variables reached statistical significance.
DISCUSSION
We have shown for the first time that there is a significant univariate correlation between serum TSA and fasting plasma insulin and glucose concentrations in young healthy subjects. Elevated fasting plasma glucose and insulin are known to be associated with increased cardiovascular disease [13, 14] and this may help to explain why an elevated serum TSA is a reputed cardiovascular risk factor [1, 2] . In addition, serum TSA correlated with serum fasting cholesterol and triacylglycerol concentrations in these individuals. The results of these correlations between serum TSA and serum lipids support earlier studies and may be due in part to sialylation of lipoproteins [5, 6, 15] . Furthermore, serum TSA and lipidassociated sialic acid are raised in an acute myocardial infarction [3] . Regarding lipid-associated sialic acid, it is known that gangliosides contain sialic acid and these may be worth exploring in cardiovascular disease and diabetes mellitus. There was no significant difference between serum TSA in males and females although SBP and serum fasting triacylglycerol were higher in the male subjects while serum HDL-cholesterol was lower. This is in keeping with previous observations [16, 17] . There were sex differences regarding the relationship between serum TSA and fasting plasma insulin and glucose concentrations. In females there was a strong univariate correlation between serum TSA and plasma fasting insulin and glucose concentrations, although in males there was only a weak univariate correlation between serum TSA and fasting plasma glucose. The difference between the sexes regarding the relationship between serum TSA and the studied variables may be relevant to the observation that serum TSA may predict cardiovascular disease more in females than males [2] . The question therefore arises of whether sex hormones are implicated in sialic acid metabolism and further studies are needed to test this idea.
Given that fasting plasma insulin and fasting glucose may be associated with insulin resistance [13, 14, 18, 19] , which is also associated with hyperlipidaemia, this may explain why serum TSA is associated with cardiovascular disease. This would tend to support the hypothesis of Flynn et al. [11] that insulin resistance may result in elevated serum TSA. The elevation of serum TSA in diabetic patients has recently been shown [7] [8] [9] [10] and is compatible with the present findings. However, the contribution to the variance of serum TSA in our multiple regression analysis by the other variables was relatively small, at best between 5 and 20 % (see Tables 3 and 4) , and presumably other factors are also relevant to serum TSA concentrations in young healthy subjects.
Serum TSA has been well described as being associated with the acute-phase protein response [20, 21] . Furthermore, it has been proposed that the reason why serum TSA is a reputed cardiovascular risk factor is that it reflects a chronic inflammatory response that may be seen in subjects with atherosclerosis [22, 23] . It is, however, unlikely that the young healthy subjects recruited in our study had significant atherosclerotic disease although this of course may be more relevant in older subjects.
Insulin resistance and hyperinsulinaemia are known to be associated with cardiovascular disease and recently Reaven's syndrome (metabolic syndrome or syndrome X) has been described in which there is a grouping of features including hypertension, raised body mass index, hyperlipidaemia and insulin resistance or hyperinsulinaemia [24] [25] [26] [27] . It is noteworthy that in our study serum TSA correlated with some of the above features and thus it may be useful to study serum TSA in this condition to help understand the pathophysiology. However, we strongly emphasize that we were not specifically studying insulin resistance syndrome in our subjects, who after all were young healthy subjects, and thus our findings only weakly and indirectly support published suggestions that serum TSA may be related to this [11] . Insulin is known to be an anabolic hormone and one of its actions is to increase certain acute-phase proteins [28, 29] . It may be that insulin resistance causes an acute-phase protein response although this needs further study ; alternatively there may be abnormalities of sialylation of glycoproteins and glycolipids in the insulin resistance syndrome. Recently there have been reports that an acute phase response mediated by cytokines may be involved in insulin resistance and metabolic syndrome X [30] [31] [32] . One of these studies looked at patients with Type II diabetes and proposed that abnormalities of the innate immune system may contribute to hypertriglyceridaemia, low HDL-cholesterol, hypertension, glucose intolerance and insulin resistance [30] , and is compatible with our findings, although we looked at apparently healthy young adults without Type II diabetes as discussed above. Nevertheless, this may be of considerable relevance to our present findings as serum TSA has been shown to be a good marker of the acute phase response [20, 21] .
In conclusion, we have shown that serum TSA is related to various known conventional cardiovascular risk factors, some of which are associated with the insulin resistance syndrome, such as lipids, blood pressure, fasting plasma glucose and insulin concentrations. The contribution of these to the variance in serum TSA is relatively small and presumably other factors are relevant to serum TSA concentrations. We believe further research is needed to explore this and to answer why serum TSA is a reputed cardiovascular risk factor.
